


















































































(GDS15)	measures		Self	(N=83)	 AES	 GDS-15	DAS	Executive	subscale	 0.76***	 0.61***	DAS	Emotional	subscale	 0.21	 0.20	DAS	Initiation	subscale	 0.79***	 0.61***	DAS	Total	 0.80***	 0.67***	Carer	(N=75)	 AES	 GDS-15	DAS	Executive	subscale	 0.82***	 0.64***	DAS	Emotional	subscale	 0.44***	 0.24*	DAS	Initiation	subscale	 0.79***	 0.65***	DAS	Total	 0.85***	 0.64***	
DAS=Dimensional	Apathy	Scale;	AES=Apathy	Evaluation	Scale;	GDS-15=Geriatric	






Subscales	(N=25)	to	patients	unimpaired	on	all	subscales	(N=34)		 ≥1	Subscale	Impairment	 Unimpaired	 p-value	ALSFRS-R	(Mean,	SD)	 38.8	(4.2)	†	 36.6	(8.8)	††	 n.s.	Disease	duration	(Median,	IQR)	 45	(53)	 98	(74)	 <.05	Age	of	Onset	(Mean,	SD)	 57.2	(11.4)	 60.6	(10.6)	 n.s.	Site	of	Onset	(%)	 	 	 		 Bulbar	(N=15)	 26.7%	 73.3%	 		 Lower	Limb	(N=21)	 47.6%	 52.4%	 	
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